Treatment of Ascending Cholangitis
Ascending cholangitis should be treated with prompt antibiotic therapy and biliary decompression, with the timing of decompression based on severity of presentation. 1, 2
Initial Assessment and Classification
Acute cholangitis is classified into three severity grades:
- Grade III (severe): Presence of organ dysfunction
- Grade II (moderate): Risk of increasing severity without early biliary drainage
- Grade I (mild): Less severe cases 2
Treatment Algorithm
1. Immediate Interventions
- Intravenous fluid resuscitation to correct hypovolemia and electrolyte imbalances
- Empiric antibiotic therapy should be started immediately after blood cultures are obtained
2. Biliary Decompression
Timing of decompression depends on severity:
- Severe cholangitis (Grade III): Urgent biliary decompression within 24 hours 2
- Moderate cholangitis (Grade II): Early biliary decompression (within 48-72 hours)
- Mild cholangitis (Grade I): Elective decompression after clinical improvement with antibiotics
Decompression methods (in order of preference):
3. Duration of Antibiotic Therapy
- Immunocompetent patients with adequate source control: 4 days
- Immunocompromised or critically ill patients: Up to 7 days 2
Management of Specific Scenarios
Recurrent Cholangitis
- Evaluate for underlying strictures or incomplete biliary drainage 2
- Consider long-term maintenance antibiotic therapy for recurrent episodes 2
- For patients with bacterial cholangitis refractory to treatment, evaluate for liver transplantation 2
Cholangitis with Biliary Stents/Drains
- Immediate flushing of biliary drains in febrile patients using sterile technique and normal saline (10-20 mL) 2
- Obtain bile samples for culture and sensitivity testing 2
- Monitor for resistant organisms with prolonged/recurrent antibiotic use 2
Cholangitis in PSC (Primary Sclerosing Cholangitis)
- Acute bacterial cholangitis should be treated with antibiotics and subsequent biliary decompression if an underlying relevant stricture is present 1
- For patients with PSC and recurrent bacterial cholangitis not controlled by antibiotics, consider liver transplantation 1
Common Pitfalls and Caveats
- Delayed biliary decompression in severe cases can lead to increased mortality
- Inadequate antibiotic coverage - consider local resistance patterns when selecting empiric therapy
- Incomplete biliary drainage is a risk factor for recurrent cholangitis 2
- Prolonged antibiotic use increases risk of developing resistant organisms 2
- Routine addition of metronidazole to third-generation cephalosporins has not been shown to improve outcomes when efficient biliary drainage is performed 3
Early diagnosis and prompt treatment are crucial to prevent the potentially fatal progression of ascending cholangitis, with mortality rates historically reported between 11-27% in severe cases 4.